nano | Last update posted in the last 14 days
Hybrid Ceramic on Worn Dentition Patients
Mon, 01 Mar 2021 12:00:00 EST
Condition:   Dental Wear
Intervention:   Procedure: Hybrid composite nano-ceramic
Sponsors:   National Taiwan University Hospital;   Taipei Medical University Hospital
Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone
Mon, 01 Mar 2021 12:00:00 EST
Condition:   Bone Augmentation
Interventions:   Procedure: Perforated collagen membrane;   Procedure: Occlusive collagen membrane
Sponsor:   Ain Shams University
Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection
Wed, 10 Feb 2021 12:00:00 EST
Condition:   SARS-CoV-2
Intervention:   Drug: EXO-CD24
Sponsor:   Tel-Aviv Sourasky Medical Center
Pharmacokinetics and Metabolism of 14 Carbon [14C]-GSK3640254
Tue, 11 Aug 2020 12:00:00 EDT
Condition:   HIV Infections
Interventions:   Drug: GSK3640254 Oral tablet;   Drug: [14C]-GSK3640254 intravenous infusion;   Drug: [14C]-GSK3640254 powder
Sponsor:   ViiV Healthcare
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
Wed, 15 Jul 2020 12:00:00 EDT
Condition:   Glioblastoma Multiforme
Intervention:   Device: Optune®
Sponsor:   NovoCure GmbH
Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
Thu, 14 May 2020 12:00:00 EDT
Conditions:   Recurrent Malignant Glioma;   Brain Glioblastoma
Interventions:   Drug: OKN-007;   Drug: Temozolomide (TMZ)
Sponsor:   Oblato, Inc.
Use of Nanoscaffold Augmentation in Rotator Cuff Repair: Clinical Outcome and Ultrasound Assessment of Healing Rates and Vascularity
Fri, 24 Apr 2020 12:00:00 EDT
Conditions:   Rotator Cuff Tears;   Rotator Cuff Injuries;   Rotator Cuff Syndrome of Shoulder and Allied Disorders
Interventions:   Device: Rotium nanoscaffold;   Procedure: Control arm rotator cuff repair
Sponsors:   Joshua Szabo, MD;   Atreon Orthopedics
Not yet recruiting
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
Thu, 10 Oct 2019 12:00:00 EDT
Condition:   Glioblastoma
Interventions:   Drug: Olaptesed pegol;   Radiation: Radiotherapy
Sponsor:   NOXXON Pharma AG
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
Fri, 04 Oct 2019 12:00:00 EDT
Condition:   Glioblastoma Multiforme
Interventions:   Drug: Valganciclovir Tablets;   Drug: Temozolomide 120 mg;   Radiation: Radiotherapy 60 Gy;   Drug: Placebo oral tablet
Sponsors:   Cecilia Soderberg-Naucler;   Karolinska University Hospital;   Karolinska Institutet
CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Mon, 14 Dec 2015 12:00:00 EST
Condition:   Candidiasis, Chronic Mucocutaneous
Intervention:   Drug: Amphotericin B
Sponsor:   Matinas BioPharma Nanotechnologies, Inc.
Active, not recruiting
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Wed, 13 May 2015 12:00:00 EDT
Conditions:   Diabetes;   Diabetes Mellitus, Type 1
Interventions:   Drug: NNC0114-0006;   Drug: liraglutide;   Drug: placebo
Sponsor:   Novo Nordisk A/S
Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
Mon, 12 Jan 2015 12:00:00 EST
Condition:   Glioblastoma
Interventions:   Drug: Durvalumab;   Radiation: Standard radiotherapy;   Biological: Bevacizumab
Sponsors:   Ludwig Institute for Cancer Research;   MedImmune LLC;   Cancer Research Institute, New York City;   Cure Brain Cancer Foundation, Australia
Active, not recruiting
Feed Fetched by RSS Dog.